TransCode Therapeutics, Inc. earnings per share and revenue

RNAZ earnings per share for the last quarter are -0.74 USD whereas the estimation was -0.58 USD which accounts for -27.59% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.49 USD, and revenue is expected to reach 300.00 k USD. Also watch annual changes over time to get a bigger picture of RNAZ earnings per share and revenue dynamics.